Skip to content

Use of high pressure oxygen as a new approach in treatment after brain haemorrhage

Impact of Hyperbaric Oxygen Therapy (HBOT) in cerebral vasospasm after Sub-Arachnoid Hemorrhage (SAH) - a comparison study with and without HBOT

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/10/058670
Enrollment
26
Registered
2023-10-16
Start date
Unknown
Completion date
Unknown
Last updated
2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I609- Nontraumatic subarachnoid hemorrhage, unspecified

Interventions

Intervention1: Hyperbaric Oxygen Therapy in addition to conventional management: 100% oxygen will be delivered through a mask in a closed chamber at 2.2 bar pressure. Each session lasts for 2 hours an

Sponsors

Amrita Institute of Medical Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: First time SAH Cerebral vasospasm with clinical cognitive decline and neurological deficits

Exclusion criteria

Exclusion criteria: Hemodynamic instability Previous history CVA Neurodegenerative diseases Tumors Fractures Deformities Amputations Middle ear barotrauma Chronic otitis media Chronic obstructive pulmonary disease Pulmonary blebs Clinical depression impeding rehabilitation compliance

Design outcomes

Primary

MeasureTime frame
Modified Rankin scaleTimepoint: Baseline before starting HBOT 1 month after SAH 3 months after SAH 6 months after SAH

Secondary

MeasureTime frame
Changes in CT Hounsfield unitsTimepoint: Baseline before starting HBOT After 5 sessions of HBOT After 10 sessions of HBOT;Changes in spasticity using Modified Ashworth ScaleTimepoint: Baseline before starting HBOT 1 month after SAH 3 months after SAH 6 months after SAH;Disability rating scaleTimepoint: Baseline before starting HBOT 1 month after SAH 3 months after SAH 6 months after SAH;Stroke Specific Quality of Life questionnaireTimepoint: Baseline before starting HBOT 1 month after SAH 3 months after SAH 6 months after SAH

Countries

India

Contacts

Public ContactDachepalli Satya Sreekar

Amrita Institute of Medical Sciences

ravisankaran@aims.amrita.edu04842851234

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026